Compare Global Payments Inc (GPN) vs ResMed Inc. (RMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Global Payments Inc vs ResMed Inc. — how do they compare? Global Payments Inc trades at $82.2 (market cap $21.46B), while ResMed Inc. trades at $230.05 (market cap $31.89B). The key difference: ResMed Inc. is the larger of the two by market cap, and Global Payments Inc pays the higher dividend (1.23%). Which is the better fit depends on your goals — on Pluang, investors hold Global Payments Inc for 50 Days and ResMed Inc. for 51 Days on average.
| GPN | RMD | |
|---|---|---|
Market Cap | $21.46B | $31.89B |
Volume | 1,482,600 | 618,314 |
Sector | Financials | Health |
52-Week High | $94.83 | $275.96 |
52-Week Low | $62.47 | $182.82 |
Typical Hold Time | 50 Days | 51 Days |
Enterprise Value | $39.60B | $31.24B |
Dividend Yield | 1.23% | 1.16% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Global Payments (GPN) trades at $82.77, up 2.08% with neutral technical signals and bullish moving averages. The company shows strong earnings momentum with three consecutive quarterly beats, though 2026 projections indicate potential profitability challenges. Recent developments include the Genius platform expansion and Worldpay integration driving growth opportunities, while elevated debt levels and competitive pressures present headwinds.
The stock offers 24% upside to the $102.75 consensus target with strong analyst support (59% buy ratings), but investors face risks from declining 2026 profitability projections and rising debt-to-asset ratios. The company's digital payment initiatives provide growth catalysts, though execution risks and margin pressures require careful monitoring.
ResMed (RMD) trades at $226.73, up 0.33% today, with a bullish technical signal from moving averages and a neutral RSI. The company reported strong earnings beats in recent quarters, with Q3 2026 results pending. Revenue grew to $5.15 billion in 2025, with a net income margin of 26.94%, while cash flow from operations reached $1.75 billion. Recent news highlights an upcoming Q1 2027 earnings report and management's focus on 12%-14% EPS growth driven by demand in sleep therapy.
The outlook for RMD is positive, supported by robust fundamentals and analyst consensus, though risks include competitive pressures and ongoing legal investigations. Upside potential exists with a consensus price target of $242.70, representing a 7% increase from current levels, but investors should monitor execution against growth targets and market share dynamics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Global Payments Inc
Global Payments is a leading provider of payment processing and software solutions and focuses on serving small and midsize merchants. The company operates in 30 countries and generates about one fourth of its revenue from outside North America, primarily in Europe and Asia. In 2019, Global Payments merged with Total System Services in an all-stock deal that gave Total System Services shareholders 48% of the combined company's shares.
Read more on GPN →About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →
